P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR

Abstract

The hepatic hemodynamic study (HH) and the transjugular liver biopsy (TJLB) are complementary tests used in hepatology that provide valuable information, allowing to obtain diagnoses that change behavior. In our environment there is little experience regarding the performance and results obtained, particularly when it is performed by a hepatologist. To describe the experience and results of the HH and TJLB study in our center. All HH and TJLB studies conducted by one of the authors (AU) from January 2018 to July 2019 were included. Clinical records, HH and TJLB outcome, and behavior change were reviewed. 25 patients and 27 procedures were included; age 55 (20-72) years, 60% women. Procedures: 21 TJLB + HH and 6 HH. Reason for request: etiological study cirrhosis 29.6%, etiology acute hepatitis 18.5%, diagnostic doubt in alcohol hepatitis 11.1%, suspected idiopathic portal hypertension 11.1%, rejection 7.4%, hepatocelullar carcinoma 3,7% and another 18.5%. In 92.6% of the cases, the HH and / or TJLB result made it possible to confirm / rule out diagnosis and change therapeutic behavior. 90.5% of the TJLB results were satisfactory for diagnosis. Only one patient presented a complication: hemobilia that did not require invasive management, and one patient had an incomplete procedure. Our experience shows that the HH study and the TJLB are important complementary tests to change behavior. For this reason, they should be considered, when indicated, in the study of the hepatological patient.